Herman van Praag

Q: What Schools Are Affiliated With Herman van Praag

Herman van Praag is affiliated with the following schools: University of Amsterdam, Albert Einstein College of Medicine, Utrecht University, University of Groningen, Maastricht University, Leiden University

Herman van Praag's AcademicInfluence.com Rankings

Herman van Praag

Economics

#2307

World Rank

#2637

Historical Rank

economics Degrees

Download Badge

Economics

Herman van Praag's Degrees

PhD Economics University of Amsterdam

Why Is Herman van Praag Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Herman Meïr van Praag is a Dutch psychiatrist. He was a professor of psychiatry at the University of Groningen, Utrecht University, Albert Einstein College of Medicine and Maastricht University. Van Praag is considered the founder of biological psychiatry in the Netherlands. After his retirement he has written extensively on religiosity.

(See a Problem?)

Herman van Praag's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The role of serotonin in schizophrenia. (1988) (414)
The measurement of suicidality, aggressivity and impulsivity (1989) (307)
Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation (1999) (275)
Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. (1987) (262)
Can stress cause depression? (2005) (259)
Serotonin and anxiety revisited (1988) (252)
Efficacy and Safety of Fluoxetine in the Treatment of Patients With Major Depression After First Myocardial Infarction: Findings From a Double-Blind, Placebo-Controlled Trial (2000) (240)
Interrelationships among anxiety, aggression, impulsivity, and mood: A serotonergically linked cluster? (1990) (214)
Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens (1991) (201)
Depression, suicide and the metabolism of serotonin in the brain ☆ (1982) (189)
Correlates of suicide and violence risk 1: the suicide risk measure. (1989) (177)
Behavioral indications for serotonin receptor hypersensitivity in panic disorder (1988) (176)
Correlates of suicide and violence risk: III. A two-stage model of countervailing forces (1989) (169)
Cerebral monoamines and depression. An investigation with the Probenecid technique. (1973) (166)
Monoamines and Abnormal Behaviour a Multi-Aminergic Perspective (1990) (165)
Hormonal probes of central serotonergic activity: Do they really exist? (1987) (155)
Amine metabolism in the human brain: further evaluation of the probenecid test. (1971) (141)
Clinical significance of probenecid test. (1973) (123)
Correlates of risk of suicide in violent and nonviolent psychiatric patients. (1991) (116)
On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs. (1977) (115)
Suicidal behaviors in adult psychiatric outpatients, I: Description and prevalence. (1993) (113)
Central serotonin metabolism and frequency of depression (1979) (109)
Is there a relation between the seriousness of suicidal intent and the lethality of the suicide attempt? (1989) (107)
Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. (1971) (105)
Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization Collaborative Study. (1982) (102)
The role of serotonin in schizophrenia (1995) (101)
Critical Appraisal of the Evidence (1986) (96)
High cholesterol levels in patients with panic disorder. (1992) (95)
Treatment of depression in Parkinson's disease: a meta-analysis. (1995) (92)
The nature of impulsivity: Definitions, ontology, genetics, and relations to aggression. (1995) (92)
Color blindness linkage to bipolar manic-depressive illness. New evidence. (1979) (87)
Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder (2004) (86)
A self-report measure of violence risk, II. (1990) (86)
In search of the mode of action of antidepressants 5-HTP/tyrosine mixtures in depressions (1983) (84)
Interconvertability of five self-report measures of depression (1987) (84)
The effect of stress on the dexamethasone suppression test (1985) (82)
Stress, the Brain and Depression (2004) (81)
Mood congruent memory bias induced by tryptophan depletion (2002) (81)
Cerebrospinal fluid 5-hydroxyindolacetic acid and aggression: a critical reappraisal of the clinical data. (1995) (80)
Amine Hypotheses of Affective Disorders (1978) (79)
Specificity of the tryptophan depletion method (1999) (79)
Depression vulnerability and 5-hydroxytryptophan prophylaxis (1980) (78)
Biological suicide research: Outcome and limitations (1986) (76)
Correlates of suicide and violence risk in an inpatient population: Coping styles and social support (1993) (72)
Depression, suicide and the metabolism of serotonin in the brain. (1982) (71)
Defense mechanisms in risk of suicide and risk of violence. (1989) (69)
Tryptophan treatment of aggressive psychiatric inpatients (1990) (67)
An empirical study on the “cathartic effect” of attempted suicide (1985) (67)
The MCPP challenge test in schizophrenia: Hormonal and behavioral responses (1991) (67)
Over the mainstream: diagnostic requirements for biological psychiatric research (1997) (66)
Therapeutic indications for serotonin-potentiating compounds: A hypothesis (1987) (65)
Plasma concentrations of diazepam and of its metabolite N‐desmethyldiazepam in relation to anxiolytic effect (1974) (65)
Controlled study comparing nomifensine and clomipramine in unipolar depression, using the probenecid technique. (1977) (65)
Faulty cortisol/serotonin interplay. Psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCA depression) (1996) (64)
The neuroendocrine response to fenfluramine in depressives and normal controls (1988) (64)
Role Of Serotonin In Psychiatric Disorders (2023) (63)
Postsynaptic serotonergic activity in depressive patients: Evaluation of the neuroendocrine strategy (1982) (59)
New Evidence of Serotonin-Deficient Depressions (1977) (59)
Reconquest of the subjective. Against the waning of psychiatric diagnosing. (1992) (55)
Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects (1990) (53)
Mania : an evolving concept (1980) (53)
Violence and suicidality : perspectives in clinical and psychobiological research (2014) (52)
Serotonin-related, anxiety/aggression-driven, stressor-precipitated depression. A psycho-biological hypothesis. (1996) (51)
Serotonergic dysfunction and aggression control (1991) (50)
Central serotonin metabolism and frequency of depression. (1979) (50)
Neuroendocrine disorders in depressions and their significance for the monoamine hypothesis of depression (1978) (50)
Central monoamine deficiency in depressions: causative of secondary phenomenon? (1975) (49)
Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side‐effects (1996) (49)
Homicidal behaviors among psychiatric outpatients. (1994) (47)
Serotonin receptor sensitivity and aggression (1991) (47)
Measuring Movement Disorders in Antipsychotic Drug Trials: The Need to Define a New Standard (2007) (45)
Over the mainstream: diagnostic requirements for biological psychiatric research. (1997) (43)
Serotonin metabolism in depression: clinical application of the probenecid test. (1974) (43)
Serotonin receptor sensitivity in major depression (1990) (43)
Faulty cortisol/serotonin interplay. Psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCA depression) (1996) (42)
Neuroleptics, catecholamines, and psychoses: a study of their interrelations. (1975) (42)
Human platelets possess multiple [3H]imipramine binding sites. (1984) (40)
Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects (1991) (40)
Kinetics of l-5-hydroxytryptophan in healthy subjects (1982) (39)
Two-tier diagnosing in psychiatry (1990) (39)
Panic-associated suicidal and aggressive ideation and behavior. (1997) (38)
Affective disorders and aggression disorders: evidence for a common biological mechanism. (1986) (38)
Parental loss and family violence as correlates of suicide and violence risk. (1995) (38)
Clozapine versus Perphenazine: The Value of the Biochemical Mode of Action of Neuroleptics in Predicting their Therapeutic Activity (1976) (38)
Serum tryptophan decreased, brain tryptophan increased and brain serotonin synthesis unchanged after probenecid loading. (1972) (37)
A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients. (1971) (37)
Depression type and depression severity in relation to risk of violent suicide attempt (1984) (36)
Measurement of aggression in psychiatric patients (1997) (36)
Towards a Biochemical Typology of Depression (1974) (35)
Functional interrelationship of serotonin and norepinephrine: Cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects (1992) (35)
Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine (1994) (35)
Desipramine treatment in panic disorder. (1991) (34)
Headache and Cortisol Responses to M-Chlorophenylpiperazine are Highly Correlated (1993) (34)
Anxiety and increased aggression as pacemakers of depression. (1998) (33)
Suicide Risk: Amplifiers and Attenuators. (1994) (32)
The influence of some antidepressives of the hydrazine type on the glucose metabolism in depressed patients. (1963) (32)
A serotonin hypothesis of panic disorder (1988) (32)
Pharmacokinetics and Therapeutic Efficacy of Haloperidol Decanoate after Loading Dose Administration (1986) (31)
The pitfalls of serotonin precursors as challengers in hormonal probes of central serotonin activity. (1986) (31)
Cardiac side‐effects of two selective serotonin reuptake inhibitors in middle- aged and elderly depressed patients (1998) (31)
Reconquest of the subjective. Against the waning of psychiatric diagnosing. (1992) (31)
About the centrality of mood lowering in mood disorders Plenary Lecture ECNP Congress, Monte Carlo, October 1991 (1992) (31)
Biological suicide research: outcome and limitations. (1986) (29)
Psychological test characteristics of depressed and panic patients (1990) (29)
[Predictive value of the probenecid test for the effect of L-DOPA therapy in Parkinson's disease]. (1972) (29)
The Significance of Dopamine for the Mode of Action of Neuroleptics and the Pathogenesis of Schizophrenia (1977) (29)
Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. (1990) (28)
Depression vulnerability and 5-hydroxytryptophan prophylaxis. (1980) (28)
5-HT-related, anxiety- and/or aggression-driven depression (1994) (27)
Management of depression with serotonin precursors. (1981) (27)
High-dose naloxone in tardive dyskinesia (1988) (27)
Multiple [3H]imipramine binding sites in brains of male and female Fawn-Hooded and Long-Evans rats. (1985) (26)
Serotonin and Disruptive Behaviour; A Critical Evaluation of the Clinical Data (1996) (26)
The serotonin hypothesis of (auto)aggression. Critical appraisal of the evidence. (1986) (26)
Cortisol response to intramuscular desipramine in patients with major depression and normal control subjects: A replication study (1992) (26)
CENTRAL SEROTONIN DEFICIENCY-A FACTOR WHICH INCREASES DEPRESSION VULNERABILITY? (1980) (25)
The Role of Serotonin in Depression (1989) (24)
Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy. (1974) (24)
Determination of clomipramine and desmethylclomipramine in plasma by means of liquid chromatography. (1977) (24)
Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects. (1973) (24)
Diagnosis, the Rate-Limiting Factor of Biological Depression Research (1993) (24)
5-HYDROXYTRYPTOPHAN AS AN ANTIDEPRESSANT: THE PREDICTIVE VALUE OF THE PROBENECID TEST (1974) (23)
Depression and schizophrenia (1977) (23)
Psychopathology, self-esteem, sexual and ego functions as correlates of suicide and violence risk (1995) (22)
Serotonergic dysfunction and aggression control. (1991) (22)
[Depression following a first heart infarct; similarities with and differences from 'ordinary' depression]. (1997) (22)
Increased suicidality in depression: Group or subgroup characteristic? (1988) (21)
(Des-tyrosine1)-gamma-endorphin in schizophrenia: Clinical, biochemical, and hormonal aspects (1981) (21)
Thyrotropin releasing hormone (TRH) as a possible quick-acting but short-lasting antidepressant (1975) (21)
The vital syndrome interview. A structured standard interview for the recognition and registration of the vital depressive symptom complex. (1965) (21)
The Suicide and Aggression Survey: a semistructured instrument for the measurement of suicidality and aggression. (1992) (20)
Comorbidity (Psycho) Analysed (1996) (20)
Diagnosis, the rate-limiting factor of biological depression research. (1993) (20)
Indoleamines in depression and suicide. (1986) (20)
The cognitive paradox in posttraumatic stress disorder: a hypothesis. (2004) (19)
Bioanalysis and pharmacokinetics of clomipramine and desmethylclomipramine in man by means of liquid chromatography. (1977) (19)
TRH by slow, continuous infusion: an antidepressant? (1976) (19)
The role of serotonin in schizophrenia. (1995) (19)
The scientific foundation of anti‐psychiatry (1978) (19)
Panic disorder: a biological perspective (1992) (18)
About the centrality of mood lowering in mood disorders. Plenary Lecture ECNP Congress, Monte Carlo, October 1991. (1992) (18)
New evidence of serotonin-deficient depressions. (1977) (18)
Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks (1990) (18)
Pharmacokinetics of clomipramine in depressive patients (1981) (18)
Use of naloxone in schizophrenic psychoses and manic syndromes. (1981) (18)
The diagnosis of depression in disorder. (1998) (18)
Clinical, biochemical, and hormonal aspects of treatment with des-tyr1-gamma-endorphin in schizophrenia (1984) (17)
Influence of desmethylimipramine on natural killer cell activity (1986) (17)
Two-tier diagnosing in psychiatry. (1990) (17)
A stubborn behaviour: The failure of antidepressants to reduce suicide rates (2003) (16)
Atypical cognitive profile in patients with depression after myocardial infarction. (2002) (16)
17 – Indoleamines in depression (1977) (16)
Monoamines and Depression (1969) (16)
Inflationary tendencies in judging the yield of depression research. (1998) (16)
Predicting response to levodopa. (1971) (16)
Serotonin denervation enhances responsiveness of presynaptic dopamine efflux to acute clozapine in nucleus accumbens but not in caudate-putamen (1992) (15)
A controlled comparative study of fluphenazine and fluphenazine enanthate in acute and chronic psychotic patients. (1970) (15)
Effects of haloperidol on human plasma magnesium. (1993) (15)
Anxiety/aggression--driven depression. A paradigm of functionalization and verticalization of psychiatric diagnosis. (2001) (15)
5‐HT-related, anxiety- and/or aggression‐driven depression (1994) (15)
The diagnosis of depression in disorder. (1998) (15)
Effect of tyrosine on attention deficit disorder with hyperactivity. (1988) (14)
Serotonin and Aggression. (1994) (14)
About the course of schizoaffective psychoses. (1984) (14)
4-Chloramphetamines. Chance and trend in the development of new antidepressants. (1973) (14)
L-tryptophan in depression. (1970) (14)
Suicide and violence associated with panic attacks (1992) (14)
5-Hydroxytryptophan in combination with clomipramine in “therapy-resistant” depressions (2004) (14)
The origin of CSF choline and its relation to acetylcholine metabolism in brain. (1979) (13)
Neuropeptides. A new dimension in biological psychiatry. (1980) (13)
Controlled trial of Penfluridol in Acute Psychosis (1971) (13)
The effect of milenperone on the aggressive behavior of psychogeriatric patients. A double-blind placebo-controlled study. (1985) (13)
About the impossible concept of schizophrenia. (1976) (13)
Biochemical versus psychopathological action profile of neuroleptics: a comparative study of chlorpromazine and oxypertine in acute psychotic disorders. (1975) (12)
Concerns about depression. (1995) (12)
TRH as a possible quick-acting but short-lasting antidepressant. (1975) (12)
Plasma dexamethasone and cortisol levels in depressed outpatients. (1989) (12)
In search of the mode of action of antidepressants: 5-HTP/tyrosine mixtures in depression. (1984) (12)
Studies in the mechanism of action of serotonin precursors in depression. (1984) (12)
The DSM-IV (depression) classification: to be or not to be? (1990) (12)
The role of serotonin in schizophrenia New findings (1991) (12)
Affective disorders and aggression disorders: evidence for a common biological mechanism. (1986) (12)
The DSM-IV (depression) classification: to be or not to be? (1990) (11)
The effect of milenperone on the aggressive behavior of oligophrenic patients. A double-blind placebo-controlled study. (1985) (11)
Inflationary Tendencies in Judging the Yield of Depression Research (1998) (11)
Serotonin precursors in the treatment of depression. (1982) (11)
(Auto)aggression and CSF 5-HIAA in depression and schizophrenia. (1986) (11)
Crossroads of corticotropin releasing hormone, corticosteroids and monoamines. About a biological interface between stress and depression. (2002) (11)
Serum levels of 5-hydroxyindole derivates after administration of L-5-hydroxytryptophan ethyl ester. (1976) (11)
MONOAMINES AND DEPRESSION: THE PRESENT STATE OF THE ART (1986) (11)
Schizophrenia: it's broken and it can't be fixed. A conceptual analysis at the centenary of Bleuler's Dementia praecox oder Gruppe der Schizophrenien. (2011) (10)
Past expectations, present disappointments, future hopes or psychopathology as the rate‐limiting step of progress in psychopharmacology (2001) (10)
No functional psychopharmacology without functional psychopathology (2010) (10)
A transatlantic view of the diagnosis of depressions according to the DSM III: II. Did the DSM III solve the problem of depression diagnosis? (1982) (10)
The clinical significance of halopemide, a dopamine-blocker related to the butyrophenones. (1984) (9)
No functional psychopharmacology without functional psychopathology (2010) (9)
Monoamine metabolism and depression in Parkinson patients. (1973) (9)
An attempt at indirect evaluation of the noradrenaline hypothesis. Results of a pilot study of the antidepressive qualities of p-chloro-N-methylamphetamine. (1969) (9)
Diagnosing depression--looking backward into the future. (1989) (9)
Concerns about depression (1995) (8)
Action of p-chloroamphetamine on cerebral serotonin metabolism: an hypothesis. (1972) (8)
Moving ahead yet falling behind. A critical appraisal of some trends in contemporary depression research. (1989) (8)
Central monoamine metabolism in depressions. I. Serotonin and related compounds. (1980) (8)
CENTRAL SEROTONIN DEFICIENCY—A FACTOR WHICH INCREASES DEPRESSION VULNERABILITY? (1980) (8)
Neuroendocrine disorders in depressions and their significance for the monoamine hypothesis of depression. (1978) (8)
Chemoprophylaxis of depressions. An attempt to compare lithium with 5-hydroxytryptophan. (1981) (7)
CSF 5-HIAA and suicide in non-depressed schizophrenics. (1983) (7)
Serotonin and Schizophrenia (1993) (7)
The possible significance of cerebral dopamine for neurology and psychiatry. (1967) (7)
A transatlantic view of the diagnosis of depressions according to the DSM III: I. Controversies and misunderstandings in depression diagnosis. (1982) (7)
Central monoamine metabolism in depressions. II. Catecholamines and related compounds. (1980) (6)
In search of the mode of action of antidepressants. 5-HTP/tyrosine mixtures in depressions. (1983) (6)
Itinerary: Concerning the professional and spiritual objectives of my life. (2003) (6)
Importance of dopamine metabolism for clinical effects and side effects of neuroleptics. (1976) (6)
Stress and suicide are we well-equipped to study this issue? (2004) (6)
Biological psychiatry: still marching forward in a dead end. (2010) (6)
Toward a biochemical classification of depression. (1974) (6)
The debit balance of present day stress research. (2004) (6)
[Depression after first myocardial infarction. A prospective study on incidence, prognosis, risk factors and treatment]. (2003) (6)
An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin. (1976) (6)
Precursors of Serotonin, Dopamine, and Norepinephrine in the Treatment of Depression (1984) (6)
Indoleamines and the central nervous system; a sounding of their clinical significance. (1970) (5)
Disease versus Dimension in Diagnosis (2010) (5)
Serotonin disturbances and suicide risk: is aggression or anxiety the interjacent link? (2000) (5)
Neuroleptics as a guideline to biological research in psychotic disorders. (1975) (5)
The treatment of schizophrenic psychoses with gamma-type endorphins. (1982) (5)
Unusual plasma level oscillations of clomipramine in man: a pharmacokinetic and pharmacodynamic dilemma. (1980) (5)
4-chloroamphetamines. Chance and trend in the development of new antidepressants. (1976) (5)
In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion. (1984) (5)
Antidepressants, catecholamines and 5-hydroxyindoles. Trends towards a more specific research in the field of antidepressants. (1967) (5)
Endorphin research in schizophrenic psychoses. (1981) (5)
Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity. (1987) (5)
An attempt at indirect evaluation of the noradrenaline hypothesis. (1973) (5)
Biological psychiatry audited. (1988) (5)
The influence of probenecid on the metabolism of serotonin, dopamine and their precursors in man (2004) (5)
Aggression und Autoaggression (1992) (5)
On what evidence should education concerning depression be based (1999) (5)
The Vulnerable Brain: Biological Factors in the Diagnosis and Treatment of Depression (1977) (5)
Letter Hormone response to 5-HTP: a reply (1984) (5)
Glucose tolerance in depression. (1968) (5)
Serotonin in Depression and Anxiety (1990) (5)
Therapy-resistant depressions: biochemical and pharmacological considerations. (1975) (4)
A dose-response study of intravenousm-chlorophenylpiperazine in normal subjects (1992) (4)
The Interrelationship of Serotonin and Norepinephrine in man (1992) (4)
Improvement of schizophrenic patients treated with [des-Tyr1]-gamma-endorphin (DTgammaE). (1979) (4)
The probenecid test in Parkinson's disease. (1973) (4)
The position of biological psychiatry among the psychiatric disciplines. (1971) (4)
Reply to Joseph et al. (1984) (4)
Psychiatrists, beware of dichotomies! (1986) (4)
Psychopsychiatry: can psychosocial factors cause psychiatric disorders? (1979) (4)
The impact of classification on psychopharmacology and biological psychiatry (1999) (4)
Why has the antidepressant era not shown a significant drop in suicide rates? (2002) (4)
The drug-free period: A methodological issue (1990) (3)
The present and the future of serotonergic drugs (1991) (3)
Stress, the Brain and Depression by H. M. van Praag (2004) (3)
Antipsychotic properties of Des-enkephalin-gamma-endorphin in treatment of schizophrenic patients. (1982) (3)
[Treatment of refractory primary depression]. (1997) (3)
Effect of m-chlorophenylpiperazine on plasma arginine-vasopressin concentrations in healthy subjects (1992) (3)
Stress, the Brain and Depression: Life events and depression: is there a causal connection? (2004) (3)
An attempt at indirect evaluation of the noradrenaline hypothesis. (1969) (3)
Investigation of the influence of p-chloro-N-methamphetamine on the human metabolism of 5-hydroxytryptamine with high voltage electrophoresis and liquid scintillation counting. (1970) (3)
Panic disorder: A presynaptic serotonin defect? (1990) (3)
(Re-)minding our business (1990) (3)
Psychotropic Drugs in Children (1978) (3)
The scientific foundation of anti-psychiatry. (1978) (3)
Anchorpoints: an introspective (1997) (2)
Stress, the Brain and Depression: Diagnosing depression (2004) (2)
Indoleamines in depression and suicide. (1986) (2)
Biological psychiatry audited. (1988) (2)
Tablets and talking--a spurious contrast in psychiatry. (1979) (2)
Psychiatrists, beware of dichotomies! (1986) (2)
New developments in human psychopharmacology. (1974) (2)
The significance of biological factors in the diagnosis of depressions: II hormonal variables. (1982) (2)
ANTIDEPRESSANTS TODAY: CRITICAL EVOLUTION OF SOME “ESTABLISHED CONCEPTS” (1984) (2)
Stress, the Brain and Depression: Stress hormones and depression (2004) (2)
Therapy-Resistant Depressions: Biochemical and Pharmacological Considerations (1975) (2)
Neuroleptic-like and antipsychotic effects of gamma-type endorphins. (1981) (2)
Brain Serotonin, Mood-Regulation and Aggression-Regulation (1985) (2)
Suicide: CSF and neuroendocrine challenge studies (1992) (2)
[Towards deepened psychiatric diagnostics]. (2008) (2)
Similar effects of an enkephalin analog on mesolimbic dopamine release and hyperactivity in rats. (1983) (2)
[Loss of sense and meaning, a neglected topic in psychiatry]. (2010) (2)
[Current developments in the field of antidepressive agents]. (1971) (2)
E.06.01 The benefits of exercise for brain plasticity: from rodents to humans (2017) (1)
The use of the synthetic peptides gamma-type endorphins in mentally ill patients. (1982) (1)
Socio-biological psychiatry. (1981) (1)
Functionalization of Psychiatric Diagnosis (2010) (1)
Stress, the Brain and Depression: Stress, the brain and depression (2004) (1)
Emotional and nutritional deprivation. (1971) (1)
Stress, the Brain and Depression: Genetics of depression (2004) (1)
Anxiety and aggression as pacemakers of serotonin-related depression (1994) (1)
[Depression and metabolism of 5-hydroxytryptamine]. (1969) (1)
Biologic psychiatry in perspective: the dangers of sectarianism in psychiatry. V. Some inferred trends. (1972) (1)
Depression after First Myocardial Infarction (1996) (1)
Psychiatrist: Endangered species (1987) (1)
DEPRESSION (1982) (1)
Plutchik–van Praag Self-Report Depression Scale (2014) (1)
On holy cows and golden calves (2003) (1)
The significance of biological factors in the diagnosis of depressions: I. Biochemical variables. (1982) (1)
L-5-hydroxytryptophan in depression and anxiety. (1988) (1)
Disease versus Dimension in Diagnosis (2010) (1)
Religiosity, a personality trait to be reckoned within psychiatry. (2013) (1)
Anchorpoints: an introspective. (1997) (1)
[Acetylcholine and depression The monoamines barrier broken]. (1975) (1)
Significance of serotonin precursors as antidepressants. (1982) (1)
[Des-Tyr1]-gamma-endorphin in schizophrenia. (1978) (1)
Reconquest of the Subjective (1992) (1)
Neuroleptics III: Practical Guidelines for Neuroleptic Medication (1978) (1)
gamma-Type endorphins and schizophrenia. (1981) (1)
Functionalizing diagnostics. (2004) (1)
Anxiety and depression. Models of interrelation (1987) (1)
[Loss of sense and meaning, a neglected topic in psychiatry]. (2010) (0)
Does Psychiatry Really Know Solid Disease Diagnoses (2010) (0)
[The cerebral dopamine metabolism in schizophrenia]. (1975) (0)
Author's Reply (1992) (0)
Behaviour and the possibility to quantitate behaviour. An account. (1969) (0)
[Marihuana. Folklore and science]. (1971) (0)
[Position of biological psychiatry with the psychiatric disciplines]. (1970) (0)
What evidence should be presented through a CD-rom program? (1998) (0)
Antidepressants III: Specific Part (1978) (0)
Amphetamines. Misery and hope. (1972) (0)
Antidepressants I: General Part (1978) (0)
Stress, the Brain and Depression: Gene–environment correlation and interaction in depression (2004) (0)
Neuroleptics IV: Specific Part (1978) (0)
Re: Disease versus Dimension in Diagnosis (2011) (0)
5-HT and the functional approach (1987) (0)
NEU volume 9 issue 2 Cover and Front matter (1997) (0)
Significance of serotonin precursors as antidepressants. (1982) (0)
5-HTP AND LITHIUM PROPHYLAXIS IN UNI-AND BIPOLAR DEPRESSION (1981) (0)
[Comments on the impossible concept of schizophrenia (author's transl)]. (1978) (0)
Psychotropic drugs in the aged. (1977) (0)
(Re‐)minding our business (1990) (0)
Itinerary: Concerning the professional and spiritual objectives of my life (2003) (0)
[The therapeutic significance of psychopharmaceutic agents; activa et desiderata]. (1968) (0)
[Neuro-endocrine disorders in depression: their importance for the study of the pathogenesis of depression]. (1977) (0)
Biological psychiatry marching towards the future and the perils of progress (1991) (0)
Pharmacotherapy of Sexual Disorders (1978) (0)
In reply (1991) (0)
Can stress cause depression? (2005) (0)
Antidepressants II: Practical Guidelines for Antidepressant Medication (1978) (0)
Growth and inflation in psychiatry. (1981) (0)
Reply (2011) (0)
[A rational pharmacotherapy for depression]. (1973) (0)
Lundbeck-IPI-SAT-5 - What evidence should be presented through a CD-rom program? (1998) (0)
The Future of Biological Psychiatry (1997) (0)
Introduction (1997) (0)
On what evidence should education concerning depression be based? (1999) (0)
Some Biological Aspects of Depressions and Their Treatment (1978) (0)
Classification of Psychiatric Syndromes (1978) (0)
Stress, the Brain and Depression: Traumatic life events: general issues (2004) (0)
Judgement and prejudgement of psychosurgery. (1973) (0)
Rehabilitative psychiatry. (1989) (0)
A bibliography of papers on psychopharmacology by Dutch authors. (1975) (0)
Kraepelin, biological psychiatry, and beyond. (2008) (0)
[Administration of naloxone in schizophrenic psychoses and manic syndromes]. (1981) (0)
Psychotropic drugs as catalysts of scientific research. (1973) (0)
[Are mental and neurological disorders related?] (2019) (0)
[Drug therapy of acute, psychotic excitement states]. (1972) (0)
[What is self-evident but does not occur as a matter-of-course; observations on the report about biological psychiatry]. (1993) (0)
The role of serotonin in Parkinsons' Disease: An integrated approach for research of motor, cognitive and affective symptoms with functional intervention studies (1998) (0)
[Central serotonin metabolism in depression]. (1980) (0)
Observations within and beyond the boundaries of catecholamine research in psychosis. (1979) (0)
A preliminary report on some clinical and biochemical actions of Ro 4-6861, a new antidepressant. (1967) (0)
Complementary aspect in the relation between biology and psychodynamic psychiatry. (1970) (0)
[New trends in human psychopharmacology]. (1974) (0)
Psychiatrist: Endangered species (1987) (0)
[Diagnosis of depressions]. (1976) (0)
Let the facts prevail (2004) (0)
[Psychopharmaca in the aged]. (1977) (0)
[The use of lithium salts in psychiatry. Indications and practical directives]. (1973) (0)
Classification of Psychotropic Drugs (1978) (0)
[Prevention of recurring vital depressions and manic-depressive fluctuations]. (1973) (0)
Sedatives and Hypnotics (1978) (0)
The complementary aspect in the relation between biological and psychodynamic psychiatry. (1969) (0)
Serotonin in Depression and Suicide (1985) (0)
Pharmacotherapy of Addictions (1978) (0)
[Pills and talking; an apparent paradox in psychiatry]. (1979) (0)
Functional Psychopathology and the Diagnostic Process in Psychiatry (1996) (0)
Emergency Cases: Some Practical Guidelines (1978) (0)
Central serotonin deficiency--a factor which increases depression vulnerability? (1980) (0)
[Hallucinogens, a Troyan horse?]. (1968) (0)
Neuroleptics I: Development, Therapeutic Effects, Indications (1978) (0)
Remeron(mirtazapine) : the designer's approach to depression (1997) (0)
[The treatment of depressions with antidepressive agents]. (1965) (0)
Clinical Evaluation of Psychotropic Drugs (1978) (0)
Nature and nurture in affective disorder (1998) (0)
Stress, the Brain and Depression: Life events and depression: preliminary issues (2004) (0)
Neuroscientific Mirages: Are We No More Than Our Brains? (2012) (0)
[The serotonergic hypothesis in schizophrenia]. (1989) (0)
Glucose Tolerance in Depression (1968) (0)
Ataractics I: General Part (1978) (0)
Antipsychotic effect of gamma-type endorphins in schizophrenia. (1980) (0)
[Mania: clinical aspects, cause and treatment]. (1994) (0)
Symposium on lithium prophylaxis. The influence of lithium salts on the course of unipolar and bipolar depressions. Lithium prophylaxis: materilization of a chimera. (1973) (0)
Nature and nurture in affective disorder (1998) (0)
Therapy-resistant depressions. Biochemical and pharmacological considerations. Contributions to biochemistry. (1974) (0)
Stress, the Brain and Depression: Monoamines and depression (2004) (0)
A Neuroendocrine Challenge Study with M-CPP in Migraine Subjects and Normal Controls (1991) (0)
Contents of The Journal of Nervous and Mental Disease (1991) (0)
Ataractics II: Specific Part (1978) (0)
S.16.01 Stress and depression: A hypothesis on their biological interface (1996) (0)
[Pathogenesis of panic disorders]. (1989) (0)
The teaching of psychiatry: a statue without a socle. (1988) (0)
Cardiological risk factors for depressive symptoms after a first myocardial infarction. (2003) (0)
Hormone response to 5-HTP: a reply. (1984) (0)
L-8 Stressor-susceptibility, cortisol-hypersecretion, and serotonin deficiency. The major determinants of a hypothetical subtype of depression (1996) (0)
S-39-2 Stress; Corticosteroids hypersecretion; Amono-aminergic dysregulation. A depressogeniccascade (1996) (0)
[Treatment of schizophrenic psychoses with gamma-type endorphins]. (1981) (0)
Is depression a mood disorder? (1991) (0)
Recent Trends in Biological Depression Research (1985) (0)
Reply to Dr. Schmidt's remarks on the paper of H.M. van Praag "Can stress cause depression?". (2005) (0)
Biochemical and psychopathological predictors of suicidality. (1982) (0)
Serotonergic dysfunction and aggression control 1 SEROTONIN AND ( AUTO ) AGGRESSIVE BEHAVIOUR Serotonin and depression (2008) (0)
[Are disturbances in the central metabolism of dopamine specific for Parkinson's syndrome?]. (1971) (0)
Imipramine binding and cortisol in depression (1986) (0)
On teaching learning theory and behavior therapy to psychiatrists. (1986) (0)
Ontogeny of behaviour and psychiatry. An accounting for the symposium theme. (1971) (0)
Effect of des-Tyr1-gamma-endorphin on serotonin metabolism in rat brain regions. (1982) (0)
Biological Aspects of Psychoses and Their Treatment (1978) (0)
[The clinical significance of neuropeptides]. (1979) (0)
5-HT and the functional approach. (1987) (0)
Neuroleptics II: Side Effects (1978) (0)
The present and the future of serotonergic drugs (1991) (0)
Symposium on depression. Biochemical points of view and problems of registration. Introduction. (1969) (0)
S04.03 Anxiety/aggression-driven depression: A manifestation of serotonergic pathology? (2000) (0)
Psychiatry and biochemistry. (1971) (0)

This paper list is powered by the following services:

Other Resources About Herman van Praag

en.wikipedia.org

What Schools Are Affiliated With Herman van Praag?

Herman van Praag is affiliated with the following schools:

Herman van Praag's Academic­Influence.com Rankings